TREVISAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 7.966
AS - Asia 7.378
EU - Europa 4.160
SA - Sud America 1.269
AF - Africa 182
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.982
Nazione #
US - Stati Uniti d'America 7.522
SG - Singapore 2.746
HK - Hong Kong 1.331
CN - Cina 1.159
BR - Brasile 952
VN - Vietnam 936
RU - Federazione Russa 916
IT - Italia 779
DE - Germania 510
IE - Irlanda 498
SE - Svezia 396
CA - Canada 344
FR - Francia 245
IN - India 225
FI - Finlandia 178
GB - Regno Unito 177
ID - Indonesia 141
BD - Bangladesh 136
AR - Argentina 125
KR - Corea 97
IQ - Iraq 91
UA - Ucraina 84
TR - Turchia 78
NL - Olanda 76
PK - Pakistan 64
JP - Giappone 59
PH - Filippine 58
ES - Italia 55
SA - Arabia Saudita 53
ZA - Sudafrica 52
MX - Messico 48
AT - Austria 47
EC - Ecuador 44
VE - Venezuela 41
MA - Marocco 33
DK - Danimarca 31
CO - Colombia 30
PL - Polonia 25
TN - Tunisia 25
MY - Malesia 24
BE - Belgio 23
CL - Cile 23
UZ - Uzbekistan 23
AU - Australia 18
PE - Perù 18
CZ - Repubblica Ceca 17
EG - Egitto 17
PY - Paraguay 17
TH - Thailandia 17
NP - Nepal 16
AE - Emirati Arabi Uniti 15
CH - Svizzera 15
CR - Costa Rica 13
JO - Giordania 12
UY - Uruguay 12
IR - Iran 11
KE - Kenya 11
DZ - Algeria 10
ET - Etiopia 10
GR - Grecia 9
LT - Lituania 9
OM - Oman 9
IL - Israele 8
LB - Libano 8
PS - Palestinian Territory 8
TW - Taiwan 8
AZ - Azerbaigian 7
BG - Bulgaria 7
EE - Estonia 7
HN - Honduras 7
HR - Croazia 7
JM - Giamaica 7
KG - Kirghizistan 7
RS - Serbia 7
BO - Bolivia 6
HU - Ungheria 6
PT - Portogallo 6
DO - Repubblica Dominicana 5
NO - Norvegia 5
PA - Panama 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
BH - Bahrain 4
GT - Guatemala 4
KZ - Kazakistan 4
NG - Nigeria 4
RO - Romania 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BY - Bielorussia 3
CM - Camerun 3
CY - Cipro 3
EU - Europa 3
KW - Kuwait 3
MN - Mongolia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
AO - Angola 2
Totale 20.948
Città #
Singapore 1.564
Hong Kong 1.304
Ashburn 726
San Jose 684
Ann Arbor 669
Dublin 484
Chandler 403
Fairfield 387
Ho Chi Minh City 313
Frankfurt am Main 306
New York 302
Toronto 293
Chicago 272
Princeton 224
Beijing 221
Hanoi 211
Santa Clara 209
Los Angeles 208
The Dalles 208
Houston 186
Hefei 181
Wilmington 177
Woodbridge 175
Seattle 159
Lauterbourg 149
Milan 142
Helsinki 122
Cambridge 119
Dallas 119
Lawrence 108
Jakarta 106
Altamura 99
Seoul 81
São Paulo 80
Moscow 76
Shanghai 67
Council Bluffs 66
Nuremberg 57
Buffalo 51
Munich 47
San Diego 47
Tokyo 46
London 42
Rio de Janeiro 41
Rome 41
Salt Lake City 40
Baghdad 39
Jacksonville 39
Da Nang 34
Chennai 32
Haiphong 32
Dhaka 29
Guangzhou 27
Lappeenranta 27
Belo Horizonte 26
Orem 26
Andover 24
Brooklyn 24
Riyadh 24
Stockholm 24
Curitiba 23
Turku 23
Brussels 22
Atlanta 21
Brasília 20
Dearborn 20
Jeddah 20
Lahore 20
Nanjing 20
Tampa 20
Boardman 19
Elk Grove Village 19
Mumbai 19
Tashkent 19
Istanbul 18
Amsterdam 17
Johannesburg 17
Biên Hòa 16
Florence 16
Kent 16
Montreal 16
Phoenix 16
Pune 16
San Francisco 16
Vienna 16
Boston 15
Caracas 15
Guayaquil 15
Hải Dương 15
Lima 15
Quito 15
Bergamo 14
Hangzhou 14
Paris 14
Quận Bình Thạnh 14
Warsaw 14
Buenos Aires 13
Changsha 13
Falls Church 13
Ha Long 13
Totale 12.696
Nome #
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched Italian multicenter study. 393
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events: A randomized controlled trial 368
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial 296
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study 286
Effects of a low glycemic index high in fiber diet on blood glucose in women with gestational diabetes 285
Independent association of estimated pulse-wave velocity with all-cause mortality in individuals with type 2 diabetes 278
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 276
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 273
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 260
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 251
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 248
Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study 247
Continuous subcutaneous insulin infusion in Italy: Third national survey 247
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 229
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study 220
Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study 217
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 214
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial 205
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy 194
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue 191
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 190
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial 188
Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 186
Open questions on basal insulin therapy in T2D: a Delphi consensus 182
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality 181
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study 181
Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors 176
Pre-gestational diabetes during the COVID-19 pandemic in Bergamo, Italy 175
Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies 175
Telemedicine home-based management in patients with chronic heart failure and diabetes type II: study protocol for a randomized controlled trial 174
Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems 171
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial 165
Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment 164
Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus 163
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control 162
The Hyperfiltering Kidney in Diabetes 159
Blood pressure and metabolic effects of acetyl-L-carnitine in type 2 diabetes: DIABASI randomized controlled trial 157
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes 155
"Insulin autoimmune syndrome": Two very different cases [“Insulin autoimmune syndrome”: Due casi molto diversi] 155
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study 155
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 152
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 151
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 151
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus 151
Kidney function in acromegaly: evidence from a long-term observational study 149
Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 149
La malattia renale e le sue complicanze: percorso per una diagnosi precoce e gestione multidisciplinare 149
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study 149
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: A multicenter case-control retrospective observational study 149
Does denosumab exert a protective effect against COVID-19? Results of a large cohort study 148
Dapagliflozin and cardiovascular outcomes in type 2 diabetes 148
Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study 148
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 147
Maternal glycaemic levels are associated with incidence of large for gestational age neonates in type 1 diabetic women in pregnancy 146
Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy 145
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study 143
Preventing microalbuminuria in type 2 diabetes 142
Gestione multidisciplinare del paziente con sindrome coronarica acuta e diabete mellito: Dalla terapia antitrombotica al trattamento dell'iperglicemia 138
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 138
Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: Findings from an administrative database 136
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial 135
Resilience in pregnant women with pre-gestational diabetes during COVID-19 pandemic: the experience of the Papa Giovanni XXIII Hospital in Bergamo, Italy 135
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 134
Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study 134
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial 133
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus 132
Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation 132
Lipids and renal disease 131
Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin-dependent diabetes mellitus 131
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 131
Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial 129
Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 129
Relationship between degree of risk factor control and all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 128
Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 128
Impact of a complement factor H gene variant on renal dysfunction, cardiovascular events and response to ACE inhibitor therapy in type 2 diabetes 127
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes 126
A holistic approach to managing cardio-kidney metabolic syndrome: insights and recommendations from the Italian perspective 126
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin 126
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus 125
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial 125
Association between age at diagnosis and all-cause mortality in type 2 diabetes: the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study 124
Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 123
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 120
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group 118
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus 117
Diabetes mellitus in critical jobs [Diabete mellito in attività lavorative critiche] 117
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 117
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes 117
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial 115
Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012 115
Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes 114
Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics 114
Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience 114
Treatment of diabetes in patients with kidney disease 114
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial 114
The high hourly overnight variability of insulin requirements as an explanation for the superiority of automated insulin delivery systems 114
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial) 112
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial 112
Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study from Five Local Healthcare Units in the Lombardy Region of Italy 111
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes 110
Totale 16.430
Categoria #
all - tutte 90.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 0 0 0 0 0 94 109
2021/20221.202 99 85 90 67 23 42 60 58 41 256 73 308
2022/20231.926 217 589 154 104 165 327 5 84 114 45 64 58
2023/20241.789 53 48 63 68 264 416 302 61 252 43 22 197
2024/20254.762 249 483 171 193 449 222 198 136 745 717 462 737
2025/20269.848 1.113 886 623 999 1.110 587 1.777 586 840 828 499 0
Totale 21.628